W & C IP
Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing a HERV-K envelope protein using an anti-HERV-K envelope protein antibody
The present invention relates to a novel antibody against HERV-K envelope that targets a conserved region not affected by glycosylation or by native conformation, and its use in diagnostics and/or in therapy.
GENEURO SA THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
A G G C G C G C C C C G A C A C C A A A C G G A G C A A G C C A A A G C C G G A C G C G C A A A A A C C A C A G C C C A A C A
A61P G01N G01N C07K G01N C07K G01N C07K C12N C12Q C12N G01N A61K C07K A61K C12N C07K A61K A61P A61K C07K G01N G01N A61P G01N C07K A61K A61K G01N C07K C07K A61P A61P A61K G01N C12N C07K G01N G01N A61K C07K G01N C07K G01N C07K A61K A61P A61P A61P A61K C12N C12N A61P C12N A61K G01N C07K C12N C07K A61K A61P C07K A61P
additional additional additional additional additional additional additional additional additional additional additional additional additional additional additional additional additional additional additional additional additional additional additional additional inventional additional additional additional inventional inventional inventional additional additional additional additional additional additional inventional additional additional additional additional additional additional inventional additional additional additional inventional additional additional additional additional additional additional additional additional additional inventional additional additional additional additional
Myound-Hwa Joseph Perry Julie Hervé Avindra Wenxue
Lee Steiner Medina Perron Nath Li